4502 武田薬品工業

累計 / 通期：4Q / 3Q / 2Q / 1Q

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	4,505,720	408,761	9.1%	-	-	191,762	4.3%	121.75	-1.7%	19.3%	0.0%	77.7%
2025/03	4Q	4,581,551	342,586	7.5%	-	-	107,928	2.4%	68.36	7.5%	60.0%	0.0%	-25.1%
2024/03	4Q	4,263,762	214,075	5.0%	-	-	144,067	3.4%	92.09	5.9%	-56.4%	0.0%	-54.6%
2023/03	4Q	4,027,478	490,505	12.2%	-	-	317,017	7.9%	204.29	12.8%	6.4%	0.0%	37.8%
2022/03	4Q	3,569,006	460,844	12.9%	-	-	230,059	6.4%	147.14	11.6%	-9.5%	0.0%	-38.8%
2021/03	4Q	3,197,812	509,269	15.9%	-	-	376,005	11.8%	240.72	-2.8%	407.2%	0.0%	749.9%
2020/03	4Q	3,291,188	100,408	3.1%	-	-	44,241	1.3%	28.41	56.9%	-51.0%	0.0%	-59.5%
2019/03	4Q	2,097,224	204,969	9.8%	-	-	109,126	5.2%	113.50	-	-	-	-

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	4,505,720	408,761	9.1%	-	-	191,762	4.3%	121.75	-1.7%	19.3%	0.0%	77.7%
2025/03	4Q	4,581,551	342,586	7.5%	-	-	107,928	2.4%	68.36	7.5%	60.0%	0.0%	-25.1%
2024/03	4Q	4,263,762	214,075	5.0%	-	-	144,067	3.4%	92.09	5.9%	-56.4%	0.0%	-54.6%
2023/03	4Q	4,027,478	490,505	12.2%	-	-	317,017	7.9%	204.29	12.8%	6.4%	0.0%	37.8%
2022/03	4Q	3,569,006	460,844	12.9%	-	-	230,059	6.4%	147.14	11.6%	-9.5%	0.0%	-38.8%
2021/03	4Q	3,197,812	509,269	15.9%	-	-	376,005	11.8%	240.72	-2.8%	407.2%	0.0%	749.9%
2020/03	4Q	3,291,188	100,408	3.1%	-	-	44,241	1.3%	28.41	56.9%	-51.0%	0.0%	-59.5%
2019/03	4Q	2,097,224	204,969	9.8%	-	-	109,126	5.2%	113.50	-	-	-	-